drugset / Trial / NCT06736587
Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
RandomizedSequentialTriple-blindTreatment
Summary
The safety and tolerability of single and multiple administration of DWP212525
Timeline
- Start
- 2024-12-10
- Primary completion
- 2026-12-30
- Completion
- 2027-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWP212525 | Unknown | — | — |